Literature DB >> 12904060

Selective formation of homo- and heterobivalent peptidomimetics.

Mookda Pattarawarapan1, Samuel Reyes, Zebin Xia, Maria C Zaccaro, H Uri Saragovi, Kevin Burgess.   

Abstract

Methodology is presented for assembling fluorescently labeled bivalent molecules from monovalent constituents, without side chain protection or coupling agents. To illustrate the procedure, a series of bivalent peptidomimetics directed toward the Trk receptors were prepared and screened via fluorescent activated cell sorting scan assays.

Mesh:

Substances:

Year:  2003        PMID: 12904060     DOI: 10.1021/jm034103e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Universal peptidomimetics.

Authors:  Eunhwa Ko; Jing Liu; Lisa M Perez; Genliang Lu; Amber Schaefer; Kevin Burgess
Journal:  J Am Chem Soc       Date:  2010-12-23       Impact factor: 15.419

2.  Bivalent diketopiperazine-based tropomysin receptor kinase C (TrkC) antagonists.

Authors:  Jing Liu; Fouad Brahimi; H Uri Saragovi; Kevin Burgess
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

3.  SYNTHESIS OF 2-[3,3'-DI-(TERT-BUTOXYCARBONYL)-AMINODIPROPYLAMINE]-4,6,-DICHLORO-1,3,5-TRIAZINE AS A MONOMER AND 1,3,5-[TRIS-PIPERAZINE]-TRIAZINE AS A CORE FOR THE LARGE SCALE SYNTHESIS OF MELAMINE (TRIAZINE) DENDRIMERS.

Authors:  Abdellatif Chouai; Vincent J Venditto; Eric E Simanek; Ruth E McDermott; John A Ragan
Journal:  Organic Synth       Date:  2009-01-01

4.  Synthesis of 2,4,6-tri-substituted-1,3,5-triazines.

Authors:  Carlos A M Afonso; Nuno M T Lourenço; Andreia de A Rosatella
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

5.  Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals.

Authors:  Dianjun Chen; Fouad Brahimi; Yu Angell; Yu-Chin Li; Jennifer Moscowicz; H Uri Saragovi; Kevin Burgess
Journal:  ACS Chem Biol       Date:  2009-09-18       Impact factor: 5.100

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.